Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Tackling unexpected financial costs starts with a clear plan and small, steady changes you can implement today.
24,369 articlesUBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Coinbase announced a 14% workforce cut to accelerate a lean, AI-native operating model amid ongoing crypto market vol...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
Meta’s latest quarter hints at more than just headline growth. This article explains why some investors excited about...
If you’re wondering should apple stock before June 8, you’re not alone. This guide breaks down the catalysts, risks, ...
Delinquencies eased in March to 3.35%, though higher-severity stress remains elevated. FHA loans push delinquency sha...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
As oil costs climb, ETH faces renewed pressure, illustrating a rare inverse relationship that market trackers say cou...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
As Treasury yields rise in 2026, CDL’s $2.29 annual dividend delivers reliable monthly cash flow from a diversified m...
The S&P 500 climbs for an eighth straight week as ten of eleven sectors rise, with healthcare leading and AI-related ...